Every year, our scientists and patient advisory group identify the studies and topics creating the most impact for people living with arthritis.
Uncover Our Focus for 2026Ongoing and completed studies across our full research portfolio, from prevention and treatment to care and health systems.
Explore Our ResearchMeet the scientists, clinicians, trainees, and patient advisory board members, driving discoveries
Meet Our TeamPeople living with arthritis guide our research priorities, shape study design, and ensure our work reflects real life.
Support Arthritis Research Canada with your time and skills. Whether you want to help at an event or host your own, there is a place for you here.
Living with arthritis? Explore open studies looking for participants and help shape the future of arthritis care.
Scientific Study Title:
Research Category
Life-changing arthritis research is only possible with your help!
Reason For Research
This research is the 3rd Phase in our evaluation of Making it WorkTM program. In this phase, we are conducting a randomized controlled trial of our eLearning program—a novel intervention to help people with inflammatory arthritis maintain employment. This unique program, called Making it WorkTM, was created to improve an aspect of disease management that is too often ignored by health care professionals – the management of employment issues. It fills a gap of utmost importance in the health care services available for people with arthritis, and has a great potential for improving quality of life and reducing the cost of arthritis.
We had previously tested a face-to-face version of the program (Phase 1). We have since converted our program into a web-based program so that its benefits can be offered to a larger number of people, especially those people living in areas with few services (Phase II). Furthermore, the video group meetings are at the leading edge of trends in the field of adult education and self-management.
This research is one of few initiatives worldwide to develop and test the effectiveness of interventions specifically targeted at employment. In this age of evidence-based health care delivery, the highest level of evidence, provided by a randomized controlled trial (RCT), is needed for our research to translate into a new service offered to people with arthritis.
How was this study conducted?
Participants were recruited from across British Columbia, Alberta and Ontario. We sent letters of invitation to individuals who attended outpatient arthritis programs, rheumatoid arthritis educational workshops from Arthritis Consumer Experts, and rheumatology practices, as well as people enrolled in a benefit plan for teachers in Alberta. Participants were randomly assigned to receiving the program or receiving usual care (control group) with some written information on work and arthritis. As such, people had a 50-50 chance of receiving the program right away or having to wait until the end of the study to receive the program.
The program consists of three main components:
Currently, all participants randomized to the intervention have received the program, and some of the people randomized to usual care who have completed the five-year study period, are now receiving the program.
The Making-it-WorkTM program was successful in preventing productivity loss and work cessation longer than two months in workers with inflammatory arthritis across three Canadian provinces, over two years.
We still need to continue to follow everyone for a total of five years, with online questionnaires filled out every six months, in order for us to see whether the program prevents people from having to completely stop work due to their arthritis.
Effectiveness of the Making it WorkTM Program at Improving Presenteeism and Work Cessation in Workers with Inflammatory Arthritis – Results of a Randomized Controlled Trial. Authors: Luquini A, Zheng Y, Xie H, Backman CL, Rogers P, Kwok A, Knight A, Gignac MAM, Mosher D, Li LC, Esdaile JM2, Thorne C, Lacaille D.